chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen. Lymph nodes under left arm.; fever/Low grade fever the following day; chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Oct2021 15:30 (Lot number: Ff2590) at the age of 51 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LEXAPRO. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ER8733, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 01Apr2021, when the patient was 51 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6199, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 11Mar2021, when the patient was 51 years old, for Covid-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 13Oct2021, outcome "recovering", described as "Swollen. Lymph nodes under left arm."; PYREXIA (non-serious) with onset 13Oct2021, outcome "recovering", described as "fever/Low grade fever the following day"; CHILLS (non-serious) with onset 13Oct2021, outcome "recovering", described as "chills". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy, pyrexia, chills.  Additional information: The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Other medications in two weeks:Regular lexapro. High fever and chills that same night of the vaccine. Swollen. Lymph nodes under left arm. Low grade fever the following day. Adverse event start date: 13Oct2021, adverse event start time: 12:00 AM Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergies reported  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a other health professional refers to an approximately 14 year old male patient. Current conditions and medical history was not reported. On an unknown date in November 2013, February 2014 and May 2014, patient was vaccinated with first, second and third dose of GARDASIL injection, respectively for an unknown indication (dose and route were not reported). Concomitant medications were not reported. On 13-OCT-2014 the patient was vaccinated with GARDASIL additional fourth dose. Lot number was reported as J010668 and expiry date was 29-APR-2016. No adverse effects reported. Patient did not seek medical attention. Product quality complaint was not reported. Additional information has been requested.
fever, chills, headache, tiredness, muscle aches, joint pain nausea and soreness at injection site
Patient reports receiving 2 Pfizer COVID vaccines. The first one was on 3/17/21 with lot # EN6207 with no adverse reactions. She received her second one on 4/5/21 with lot #EP7533. She reports she started "feeling bad" 4/6/21-4/11/21. She noticed left sided neck swelling on 4/11/21. She went to urgent care and was seen by an NP and was told to go to for a CT scan the next day since it was on a Sunday.  Patient reports she went home and had further left sided neck swelling and difficulty breathing. She "couldn't catch her breath". EMS was called and she was transported per her request to Hospital. She had a 9 day hospital stay and was told she was having a severe reaction to the vaccine and that she had pneumonia with fluid in her lungs and fluid around her heart. She was treated with 2 antibiotics, IV fluids, and a diuretic. Patient had a follow up with her primary care on Monday 4/26/21 with NP and was told her heart and lungs sounded clear. She has a follow up appt scheduled with her lung doctor Dr on 5/24/21. Patient did not say why she has seen a lung doctor before but that she had been seeing this doctor prior to this adverse reaction. She was told in the hospital that it was not normal to be having this much swelling. Patient states she still feels weak and is still somewhat short of breath.
Redness, soreness, inflammation, dizziness & fainting, decrease in blood pressure, fatigueness.
Pt developed hives 19 mins. after receiving the vaccine. No resp distress noted, lungs clear, Benadryl 25 mg PO tab given.  @ 4:12pm,   Within 5 mins, hives began to subside.  Pt stated she was feeing better.   Observed for 30 mins more.  Hives lessened significantly, and pt denied any other symptoms of acute reaction. and was released home.   Husband drove pt home and she stated she would f/u  with PCP.   upon release.  No distress noted.
11/15/2022, 7:00pm -- vomited; 11/19/2022, woke up with severe hives on right leg, called after hours pediatrics, instructed to give allergy medication until hives clear -- began children's Zyrtec, continue watching for other symptoms of reaction
I woke up in the night (approx. 2:00 a.m.) with freezing cold feet and hands.  This continued throughout the night (I could not get warm) until I fully awoke at 7:00 a.m. when  took my temperature.  That was 100.6.  After speaking to my doctors office, I took Tylenol and my temperature reduced to 99.8 for the rest of the day.  By 9:00 p.m., it had gone down to normal without medication.  I still suffered from exhaustion and seem to have ongoing digestive issues.
no ae; second dose of PROQUAD was administered to a patient who is 2 years old instead of at the recommended minnimum age of 4 years old.; This spontaneous report was received from medical assistant and refers to a 2-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications was not reported.   On 25-OCT-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) subcutaneous injection, unk, lot #W019625, expiration date: 19-DEC-2023, administered for prophylaxis (strength and route of administration were not provided) (product administered to patient of inappropriate age). No additional adverse events were reported (no adverse event).
developed sore arm that lasted for 2 days.  no treatment was obtained and after the 2 days arm soreness reduced to zero.
Patient received only the liquid DTaP/IPV portion of PENTACEL with no reported adverse event; Initial information received on 12-Jan-2022 regarding an unsolicited valid non-serious case from was received from the health professional.  This case involves a 7 months old male patient who received only the liquid dtap/ipv portion of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] with no reported adverse event.  The patient's past medical history, medical treatment(s), and family history were not provided.  Concomitant vaccinations included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR); and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for prophylactic vaccination.  On 29-Dec-2021, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (dosage: 0.5 ml once (Third in the series); lot number: U6940AA and expiry date: 21-May-2022) via intramuscular route in the left leg for Immunisation.  On 29-Dec-2021, the patient developed a non-serious event "patient received only the liquid dtap/ipv portion of pentacel with no reported adverse event" (incorrect dose administered) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE.  It was reported "Caller states that a patient received only the DTaP/IPV portion of the product and would like to know how to proceed? Additional Description of event Adverse events : Patient received only the liquid DTaP/IPV portion of PENTACEL. Dosage Information o Frequency = once o Therapy Date: 29Dec2021 o Route = IM Left Leg o Dose = 0.5mL o Strength = standard o Indications = Immunization  Event Information - Treatment - Dose: Third in the series "  Action taken with DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE (PENTACEL) was not applicable.  At time of reporting, the outcome was Unknown for the event patient received only the liquid dtap/ipv portion of pentacel with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
2 days post J.E. vaccine began having hives wrist and shoulder, mother treated with benadryl,  3rd day swelling toes and wrists, seen here 5/16/05 with angio edema  no resp symptoms. Treated with oral prednisone
My daughter received her 1st dose of the HPV vaccine on 6/19/17. At the beginning of July 2017, she began complaining of pain in her right wrist. I first brushed it off as growing pains, as she was an 11 year old female. She continued to complain off and on throughout the months following, August, September and October. In October of 2017, I decided to call and schedule an appointment with her pediatrician to discuss the wrist pain. Her doctor ordered an x-ray for the right wrist and also ordered blood work to be done due to patient (my daughter) losing a decent amount of weight since her physical (which was also the day she received the vaccine, 6/19/17). The x-ray came back showing thinning of the bone and inflammation around the joint in the wrist. The blood work came back and showed issues with her thyroid levels. We were then referred to two different specialists in another city, an endocrinologist and a rheumatologist. Within the next 3 weeks, patient was diagnosed with Juvenile Arthritis and Autoimmune Thyroiditis. She had never had a medical issue in the past and there is no family history of autoimmune diseases like these. Since then, the endocrinologist has got the thyroid issues under control for now with medication. The arthritis continues to be a major issue in her life. We went to occupational therapy in November of 2017 and were released in January of 2018 due to loss of all range of motion in the wrist. She is on naproxen, folic acid, methotrexate, vitamin D and levothyroxine for the juvenile arthritis and the autoimmune thyroiditis. An MRI from February of 2018 has confirmed that her wrist has permanent irreparable damage. We return to the rheumatologist on July 26th, 2017 to have another MRI to determine the next course of treatment.
ON GOING:  Rash on left arm at injection site that has not gone away   Constant tinnitus   Weight gain especially after the 2nd. I have gained 15 pounds in 6 weeks   Restlessness   Swollen hands    TEMP Adverse Events:  - headache  - arm pain  - cold sweats
EXPOSURE TO TEMPERATURE OUTSIDE RECOMMENDED STORAGE RANGE, UNKNOWN POTENCY/VIABILITY
Influenza vaccine (shot) given on 9/26/14 at pharmacy. Developed fever of 103.5, rash, HA, nausea and diarrhea on 9/29/14.
high blood pressure; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.The following information was reported: HYPERTENSION (non-serious), outcome "unknown", described as "high blood pressure". The patient underwent the following laboratory tests and procedures: blood pressure measurement: high.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
SEVERE muscle pain, burning sensation in chest cavity and espophagus, slight fever (1 degree), fatigue, headache. These were the most severe manifestations I have ever experienced. Since I have previously had anaphylaxis, I am more worried about the reactions.  I was not able yo sleep at all due to the strong pain.  I do feel better this morning, but nowhere near ok.
The patient started to experience a localized injection site reaction around the injection site, including a rash and swelling. the rash covered the upper part of the arm around the injection site and was a light pinkish/red color. the swelling covered the whole arm from the injection site to the elbow, and was more severe than the rash. the patient stated that he was in a lot of pain that radiated from the site up through his shoulder and down his whole arm. the patient stated that he started to develop pain and other symptoms starting 2 hours after the injection. he came into the following morning on 10/16/2020 to show the pharmacist his arm and voice his concerns. he then went to the emergency room where he received a decadron shot and was instructed to use OTC benadryl. the patient came back into the pharmacy this morning to let me know that he is feeling much better and has recovered.
had a lot of pain in his arm/his legs; soreness in his back; chronic soreness throughout his body; he's very very fatigued / very tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (had a lot of pain in his arm/his legs), BACK PAIN (soreness in his back), MYALGIA (chronic soreness throughout his body) and FATIGUE (he's very very fatigued / very tired) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (had a lot of pain in his arm/his legs), BACK PAIN (soreness in his back), MYALGIA (chronic soreness throughout his body) and FATIGUE (he's very very fatigued / very tired). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (had a lot of pain in his arm/his legs), BACK PAIN (soreness in his back), MYALGIA (chronic soreness throughout his body) and FATIGUE (he's very very fatigued / very tired) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were provided by the reporter. Other treatment medications include counter pain killers.
My chronic migraine issues had been resolved for nearly five years.  They returned in full force within five days of my vaccination.  When I spoke with my Neurologist he told me that ACROSS THE BOARD his migraine patients were suffering for the four months post- vaccine, that the migraine issues returned.
I started to have a swollen in my throat , my tong and lip.  I also experienced red dots  on my tong. and my arm was very itchy
Left axillary lymphadenitis; Fever max 101 for 4 days; Allergic rash ten days post vaccination; This is a spontaneous report from a non-contactable physician, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Sep2021 at 12:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sulfamethoxazole, trimethoprim (BACTRIM DS) for an unknown indication from an unknown date and unknown if ongoing. On 09Sep2021 at 18:00, the patient experienced left axillary lymphadenitis, fever max 101 for 4 days and allergic rash ten days post vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with unspecified antibiotics and antihistamine. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events left axillary lymphadenitis, fever max 101 for 4 days and allergic rash ten days post vaccination was recovering at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Congestion; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Congestion) and OROPHARYNGEAL PAIN (sore throat) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (Congestion) and OROPHARYNGEAL PAIN (sore throat). At the time of the report, NASAL CONGESTION (Congestion) and OROPHARYNGEAL PAIN (sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment medications were not reported.
Anaphylactic reaction within 20 minutes of MMR - rhinorrhea, flushing, urticaria, wheezing & emesis - given epinephrine, PRELONE & BENADRYL.  Observed in office x 2 1/2 hours.  D/c'd on prednisone & BENADRYL. 5/30/08-office notes received for DOS 5/22/08-15 minutes after MMR started having rhinorrhea, mild cough. 5 minutes later emesis, wheezing and total body urticaria. Immediate resolution after epinephrine. 45 minutes later developed worsening urticaria, redness, increase in HR, treated with benadryl with improvement. Observed 2 hours with no increase in symptoms, and improvement of pruritis and urticaria. 5/27/08 Possible gelatin allergy. MMR allergy.
After the first dose I had arm pain only and left after 40 minutes. The next day around noon I started feeling my mouth, lips and tongue hurting. It was hard to eat except yogurt but I was able to breathe fine. I also had hives on my hands and left toes. . The next day it was worse so I went to an urgent care. They prescribed methylprednisone and follow up with a doctor and allergist.  Both thought it was a delayed reaction to the vaccine. After  3 days I was able to eat more solid food. After discussions with both the doctor and allergist, since I really wanted to get the second dose, I received a prednisone prescription, epi prescription, and benadryl. I took 1 benadryl before the second shot (no zyrtec that day). I am taking benadryl  every 6 hours round the clock.  So far, I have the feelings of beginning of swelling when I don't take the benadryl promplty. I have not taken the prednisone (but will check with doctor to see if it is better to knock out the swell reaction with benadryl longer or start prednisone). I'm not sure if it is bad swelling as with the first vaccine, or minor.
Initial unsolicited report received from a medical assistant on 07-Jul-2017. This case involves a 21-months-old female patient who was vaccinated with a dose of ACT-HIB (Batch number: UI764AA, expiry date not reported) and HEPATITIS A VACCINE (Batch number: J3K9H7, expiry date not reported), via intramuscular route in right thigh and DTAP (Batch number: YA4MH, expiry date not reported), intramuscularly on 27-Jun-2017. Illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) reported as none. Any other vaccinations within 4 weeks of vaccinations was not reported. On 27-Jun-2017, same day following the vaccination, the patient became very sleepy. It was reported that the patient would wake up to eat and drink, but would fall back to sleep. No other symptoms reported. The patient required ER/doctor visit. Relevant diagnostic tests/laboratory data reported as none. The patient corrective treatment not reported. On an unknown date the patient's recovered from event (sleep lasted 3 days and then cleared up). List of documents held by sender: none.
Fifteen minutes after the shot was given,  onset of sore, scratchy throat ...as listed on the original  CDC information about possible adverse effects, allergic in particular.  Sore, scratchy throat lasted all day, fairly mild but definitely there and into the night.  Several sneezing  fits during the first day and runny nose, sore vaccination site.  Mild fever during night following, all gone the next day.  Normally I experience a shiver up the spine at the end (the first three shots), but did not this time.  Throat was very barely sore the next day. All symptoms gone by day 3.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date (reported as "about 10 years ago" and before 65 years of age), the patient was vaccinated with pneumococcal vaccine (manufacturer unknown) (dose, route of administration, lot# and expiration date were not reported). It could not be confirmed if the vaccine was Merck product. On 15-NOV-2017, the patient was vaccinated with the second dose of PNEUMOVAX 23 lot # N011305 (dose and route of administration were not reported) for prophylaxis. The pharmacist was not aware of the administration of the previous dose. No adverse reaction was reported.